Rapid Detection of Antimicrobial Resistance Genes in Critically Ill Children Using a Custom TaqMan Array Card

Bacteria are identified in only 22% of critically ill children with respiratory infections treated with antimicrobial therapy. Once an organism is isolated, antimicrobial susceptibility results (phenotypic testing) can take another day. A rapid diagnostic test identifying antimicrobial resistance (A...

Full description

Saved in:
Bibliographic Details
Main Authors: John A. Clark (Author), Martin D. Curran (Author), Theodore Gouliouris (Author), Andrew Conway Morris (Author), Rachel Bousfield (Author), Vilas Navapurkar (Author), Iain R. L. Kean (Author), Esther Daubney (Author), Deborah White (Author), Stephen Baker (Author), Nazima Pathan (Author)
Format: Book
Published: MDPI AG, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_95750dba5eda458b843f3c27c3afb7cb
042 |a dc 
100 1 0 |a John A. Clark  |e author 
700 1 0 |a Martin D. Curran  |e author 
700 1 0 |a Theodore Gouliouris  |e author 
700 1 0 |a Andrew Conway Morris  |e author 
700 1 0 |a Rachel Bousfield  |e author 
700 1 0 |a Vilas Navapurkar  |e author 
700 1 0 |a Iain R. L. Kean  |e author 
700 1 0 |a Esther Daubney  |e author 
700 1 0 |a Deborah White  |e author 
700 1 0 |a Stephen Baker  |e author 
700 1 0 |a Nazima Pathan  |e author 
245 0 0 |a Rapid Detection of Antimicrobial Resistance Genes in Critically Ill Children Using a Custom TaqMan Array Card 
260 |b MDPI AG,   |c 2023-12-01T00:00:00Z. 
500 |a 10.3390/antibiotics12121701 
500 |a 2079-6382 
520 |a Bacteria are identified in only 22% of critically ill children with respiratory infections treated with antimicrobial therapy. Once an organism is isolated, antimicrobial susceptibility results (phenotypic testing) can take another day. A rapid diagnostic test identifying antimicrobial resistance (AMR) genes could help clinicians make earlier, informed antimicrobial decisions. Here we aimed to validate a custom AMR gene TaqMan Array Card (AMR-TAC) for the first time and assess its feasibility as a screening tool in critically ill children. An AMR-TAC was developed using a combination of commercial and bespoke targets capable of detecting 23 AMR genes. This was validated using isolates with known phenotypic resistance. The card was then tested on lower respiratory tract and faecal samples obtained from mechanically ventilated children in a single-centre observational study of respiratory infection. There were 82 children with samples available, with a median age of 1.2 years. Major comorbidity was present in 29 (35%) children. A bacterial respiratory pathogen was identified in 13/82 (16%) of children, of which 4/13 (31%) had phenotypic AMR. One AMR gene was detected in 49/82 (60%), and multiple AMR genes were detected in 14/82 (17%) children. Most AMR gene detections were not associated with the identification of phenotypic AMR. AMR genes are commonly detected in samples collected from mechanically ventilated children with suspected respiratory infections. AMR-TAC may have a role as an adjunct test in selected children in whom there is a high suspicion of antimicrobial treatment failure. 
546 |a EN 
690 |a rapid diagnostic tests 
690 |a antibacterial agents 
690 |a critical illness 
690 |a child 
690 |a respiratory system 
690 |a antimicrobial resistance 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 12, Iss 12, p 1701 (2023) 
787 0 |n https://www.mdpi.com/2079-6382/12/12/1701 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/95750dba5eda458b843f3c27c3afb7cb  |z Connect to this object online.